Keigo Fujishita
Overview
Explore the profile of Keigo Fujishita including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
2
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fuji S, Yuda S, Tada Y, Kano M, Sanda K, Fujishita K, et al.
Br J Haematol
. 2023 Dec;
204(2):e25-e27.
PMID: 38053439
No abstract available.
2.
Matsumoto K, Fujishita K, Matsuda M, Oka S, Fujisawa Y, Imai T, et al.
Acta Med Okayama
. 2022 Nov;
76(5):609-615.
PMID: 36352810
A 69-year-old Japanese man with acute leukemia received post-transplant cyclophosphamide-based haploidentical stem cell transplantation (PTCY-haplo-SCT) but was readmitted with dyspnea and ground-glass-opacities of the lungs. Bronchoscopy showed inflammatory changes with...
3.
Hayashino K, Matsuda M, Fujishita K, Iwata J, Mizobuchi M, Uemura M, et al.
J Clin Exp Hematop
. 2022 Oct;
62(4):222-225.
PMID: 36261335
In the 2016 update of the World Health Organization (WHO) classification of myeloid neoplasms, acute undifferentiated leukemia (AUL) was defined by a lack of lineage-specific markers. AUL has very poor...
4.
Hayashino K, Matsuda M, Negoro T, Fujishita K, Imai T
Int J Hematol
. 2022 Sep;
116(4):461-462.
PMID: 36056989
No abstract available.
5.
Fujishita K, Yasuhisa S, Oka S, Fujisawa Y, Machida T, Imai T
Acta Med Okayama
. 2022 Mar;
76(1):17-24.
PMID: 35236994
R-CHOP therapy is generally performed every 3 weeks. We investigated the effects of extending the interval of R-CHOP therapy for > 1 week on the prognoses of patients with non-indolent...
6.
Kitamura W, Fujii N, Nawa Y, Fujishita K, Sugiura H, Yoshioka T, et al.
Int J Hematol
. 2022 Feb;
115(4):515-524.
PMID: 35119651
Background: Previous studies have revealed that relapse of myeloid neoplasms after allogeneic hematopoietic stem cell transplantation (allo-HSCT) could be predicted by monitoring Wilms' tumor 1 (WT1) mRNA expression. However, only...
7.
Fujishita K, Oka S, Kamei K, Tani K, Fujisawa Y, Kitamura W, et al.
Acta Med Okayama
. 2020 Oct;
74(5):435-441.
PMID: 33106701
A 53-year-old man was diagnosed with acute myeloid leukemia, which was refractory to chemotherapies. Systemic papules appeared afterward. The skin biopsies revealed filamentous fungal infection including fusariosis. Despite antifungal therapy,...
8.
Kitamura W, Machida T, Fujishita K, Oka S, Fujisawa Y, Tani K, et al.
Rinsho Ketsueki
. 2020 May;
61(4):312-317.
PMID: 32378572
We present the case of a 39-year-old man with a primary diagnosis of mixed phenotype acute leukemia, T/myeloid not otherwise specified (T/M-MPAL). After achieving a complete remission (CR), he underwent...